New applications of nanoparticles in cardiovascular imaging

Journal of Experimental Nanoscience

Volumn 2, Issue 1-2, 2007, Pages 115-126

  Sharma, Rakesh ^a   Kwon, Soonjo ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Contrast agents; Mice; Molecular imaging; MRI; Nanoparticles; Thrombosis

Indexed keywords

APOFERRITIN; CELL ADHESION MOLECULE; CHEMOKINE; CONTRAST MEDIUM; CYTOKINE; DENDRIMER; ENDOTHELIN 1; FIBRONECTIN; FLUOROCARBON; GROWTH FACTOR; IRON OXIDE; LIPOSOME; MYOGLOBIN; POLYMER; TROPONIN;

ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM EXAMINATION; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; HUMAN; MOLECULAR IMAGING; NANOENCAPSULATION; NANOENGINEERING; NANOIMAGING; NANOPHARMACEUTICS; NANOSENSOR; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 34248549523     PISSN: 17458080     EISSN: 17458099     Source Type: Journal    
DOI: 10.1080/17458080601101176     Document Type: Conference Paper

References (38)

1. Uwatoku, T., Shimokawa, H. and Abe, K. (2003) Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats. Circ. Res., 92, p. 62.
2. Sharma, R., Kline, RP and Wu, EX (2005) Rapid in vivo Taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-Methyl-N-Nitrosourea induced breast tumors in rats. Cancer Cell Int., 3, p. 26.
3. Matter, CM, Schuler, PK and Alessi, P. (2004) Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ. Res., 95, p. 1225.
4. Blankenberg, FG and Strauss, HW (2001) Noninvasive strategies to image cardiovascular apoptosis. Cardiol. Clin., 19, p. 165.
5. Bengel, FM, Anton, M. and Avril, N. (2000) Uptake of radiolabeled 2′-fluoro-2′-deoxy-5-iodo-1-beta-D arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: The cellular basis for cardiac gene imaging. Circulation, 102, p. 948.
6. Lanza, GM, Wallace, KD and Scott, MJ (1996) A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation, 95, p. 3334.
7. Sipkins, DA, Cheresh, DA and Kazemi, MR (1998) Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat. Med., 4, p. 623.
8. Demos, S., Alkan-Onyuksel, H. and Kane, B. (1999) In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J. Am. Coll. Cardiol., 33, p. 867.
9. Wiener, C., Brechbiel, MW and Brothers, H. (1994) Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Med., 31, p. 1.
10. Bryant, LHJ and Brechbiel, MW (1999) Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J. Magn. Reson. Med., 9, p. 348.
11. Lu, PY, Xie, F. and Woodle, MC (2005) In vivo application of RNA interference: From functional genomics to therapeutics. Adv. Genet., 54, p. 117.
12. Wu, EX, Tang, H. and Jensen, JH (2004) Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models. NMR in Biomed., 17, p. 478.
13. Hsieh, PC, Davis, ME and Gannon, J. (2006) Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest., 116, p. 2378.
14. Cyrus, T., Abendschein, DR and Caruthers, SD (2006) MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. J. Cardiovasc. Magn. Reson., 8, p. 535.
15. Loghin, C., Sdringola, S. and Gould, KL (2006) Does Coronary Vasodilation After Adenosine Override Endothelin-1 Induced Coronary Vasoconstriction?. Am. J. Physiol. Heart. Circ. Physiol., 9, p. 1.
16. Flogel, U., Laussmann, T. and Godecke, A. (2005) Lack of myoglobin causes a switch in cardiac substrate selection. Circ. Res., 96, p. 68.
17. Noon, WH and Kong, Y. (2002) Molecular dynamics analysis of a buckyball-antibody complex. Proc. Nat. Acad. Sci. USA, 99, p. 6466.
18. Roessler, BJ, Bielinska, AU and Janczak, K. (2001) Substituted beta-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem. Bioph. Res. Comm., 283, p. 124.
19. Remsen, EE and Kowalewski, T. (2001) Two-dimensional, shell-cross-linked nanoparticle arrays. J. Am. Chem. Soc., 123, p. 4627.
20. Lanza, GM, Abendschein, DR and Hall, CH (2000) In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J. Am. Soc. Echocardiog., 13, p. 608.
21. Song, SK and Chen, J. (2000) High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magnet. Reson. Med., 44, p. 867.
22. Anderson, SA, Rader, RK and Westlin, WF (2000) Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magnet. Reson. Med., 44, p. 433.
23. Flacke, S., Fischer, S. and Scott, MJ (2001) Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation, 104, p. 1280.
24. Lanza, GM and Winter, PM (2002) Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation, 106, p. 2842.
25. Kelly, KA, Allport, JR and Tsourkas, A. (2005) Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res., 96, p. 327.
26. Ruehm, SG, Corot, C. and Vogt, P. (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation, 103, p. 415.
27. Louie, AY, Huber, MM and Ahrens, ET (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol., 18, p. 321.
28. Bulte, JW, Douglas, T. and Witwer, B. (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol., 19, p. 1141.
29. Lanza, GM, Trousil, RL and Wallace, KD (1998) In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J. Acoust. Soc. Am., 104, p. 3665.
30. Lanza, GM, Abendschein, DR and Hall, CH (2000) Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest. Radiol., 35, p. 227.
31. Takeuchi, M., Ogunyankin, K. and Pandian, N. (1999) Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): In vivo experimental echocardiographic studies. J. Am. Soc. Echocardiog., 12, p. 1015.
32. Song, J. and Chappell, JC (2002) Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J. Am. Coll. Cardiol., 39, p. 726.
33. Unger, EC, McCreery, TP and Sweitzer, RH (1997) Ultrasound enhances gene expression of liposomal transfection. Invest. Rad., 32, p. 723.
34. Shohet, R., Chen, S. and Zhou, YT (2000) Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 101, p. 2554.
35. Åkerman, ME, Chan, WCW and Laakkonen, P. (2002) Nanocrystal targeting in vivo. Proc. Nat. Acad. Sci. USA, 99, p. 12617.
36. Protti, A., So, P-W, Herlihy, A. and Bell, J. (2006) SPIO positive contrast in-vivo by the use of Diagonal-SPRITE. Proc. Int. Soc. Magn. Reson. Med. USA at Seattle, p. 361. WA
37. Bulte, JW, Duncan, ID and Frank, JA (2002) In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cerebrovas. Blood Flow Met., 22, p. 899.
38. Neuberger, T., Schopf, B. and Hofmann, H. (2005) Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater., 293, p. 483.